Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Pilot Study to Test Activity of Antimalarial Drugs Against an Induced Malaria Infection in Healthy Volunteers

This study has been completed.
Sponsor:
Collaborators:
Queensland Institute of Medical Research
Q-Pharm Pty Limited
Trident Clinical Research Pty Ltd
Information provided by:
Medicines for Malaria Venture
ClinicalTrials.gov Identifier:
NCT01055002
First received: January 21, 2010
Last updated: June 23, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
No publications provided by Medicines for Malaria Venture

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):